|Biogen. HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman Syndrome: NCT05127226, ION582–CS1|2021–003009–23
Accessed August 29, 2024 at: